ÂÜÀòÂÒÂ×

Brian Rich is an accomplished scientist with extensive experience in medicinal chemistry and drug design. Currently serving as a Scientist I at Olema Oncology, Brian Rich supports programs focused on estrogen receptor alpha and kinase targets, initiating computational chemistry efforts and applying structure-based drug design. Prior roles include Principal Research Associate and Associate Scientist at BlackThorn Therapeutics, where Brian Rich contributed to CNS drug development, and Senior Research Associate at Nanosyn, specializing in organic process development. Brian Rich began a research career at UC Santa Barbara in the Lipshutz Group, developing innovative synthetic methodologies with a focus on green chemistry. Academic qualifications include a BS in Chemistry and Biochemistry from UC Santa Barbara, complemented by studies at the University of Oxford and the University of Pennsylvania.